Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Elisa Gallerani"'
Autor:
Olga Nigro, Claudio Chini, Ilaria Gioia Angiola Marcon, Annamaria De Giorgi, Linda Bascialla, Elisa Gallerani, Alice Giaquinto, Diego De Palma, Maurizio Lombardo
Publikováno v:
Dermatology Reports (2022)
Basal cell carcinoma (BCC) is the most common malignant tumor of the skin. Despite the indolent nature, metastatic BCC can occur, albeit rarely. Metastasis to the bone are very rare. From its approval, mBCC patients are treated with vismodegib, a sel
Externí odkaz:
https://doaj.org/article/5b5e2f494b5c4f95bb38bd03169bb498
Autor:
Andrea De Censi, Matteo Lazzeroni, Matteo Puntoni, Luca Boni, Aliana Guerrieri Gonzaga, Tania Buttiron Webber, Marianna Fava, Irene Maria Briata, Livia Giordano, Maria Digennaro, Laura Cortesi, Fabio Falcini, Franca Avino, Francesco Millo, Katia Cagossi, Elisa Gallerani, Alessia De Simone, Anna Cariello, Giuseppe Aprile, Maria Renne, Bernardo Bonanni
Publikováno v:
Cancer Research. 83:GS4-08
We have previously shown in a phase 3 trial that tamoxifen 5 mg/day for 3 years decreased by 52% the incidence of recurrence of invasive breast cancer or DCIS after a median follow-up of 5.1 years in women with excised non invasive breast disease, in
Data from Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers
Autor:
Eckhart Kaempgen, Thomas Woelfel, Ulf Forssmann, Ulrike Gnad-Vogt, Adrian Ochsenbein, Alexander Knuth, Lotta von Boehmer, Dagmar Hess, Steffen Böhm, Nicolas Mach, Elisa Gallerani, Volker Lennerz, Stefanie Gross
Previous cancer vaccination trials often aimed to activate CD8+ cytotoxic T-cell (CTL) responses with short (8–10mer) peptides and targeted CD4+ helper T cells (TH) with HLA class II–binding longer peptides (12–16 mer) that were derived from tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b85d5214a96713f377fd7c838d05539a
https://doi.org/10.1158/2326-6066.c.6548519.v1
https://doi.org/10.1158/2326-6066.c.6548519.v1
Autor:
Eckhart Kaempgen, Thomas Woelfel, Ulf Forssmann, Ulrike Gnad-Vogt, Adrian Ochsenbein, Alexander Knuth, Lotta von Boehmer, Dagmar Hess, Steffen Böhm, Nicolas Mach, Elisa Gallerani, Volker Lennerz, Stefanie Gross
Short peptide vaccine induces CD4+ T helper cells in patients with different solid cancers - desription of methods according to MIATA guidelines(MIATA checklist)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c553b9773f0809256a7d90dea6886ef
https://doi.org/10.1158/2326-6066.22537676
https://doi.org/10.1158/2326-6066.22537676
Autor:
Eckhart Kaempgen, Thomas Woelfel, Ulf Forssmann, Ulrike Gnad-Vogt, Adrian Ochsenbein, Alexander Knuth, Lotta von Boehmer, Dagmar Hess, Steffen Böhm, Nicolas Mach, Elisa Gallerani, Volker Lennerz, Stefanie Gross
(1) Gating strategy, (2) representative examples of the time course of spCD4 responses, (3) individual cytokine profile and magnitude of spCD4 responses of all patients with detected spCD4 T cell response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8baf70b081d605d9b36778c33745704a
https://doi.org/10.1158/2326-6066.22537679
https://doi.org/10.1158/2326-6066.22537679
Autor:
Stan B. Kaye, Jaap Verweij, Josep Tabernero, Jean Charles Soria, Richard H. Wilson, Ruth Plummer, Jeffrey Evans, Emile Voest, Nicolas Penel, Jan H.M. Schellens, Silvia Marsoni, Patrick Schöffski, Andre T. Brunetto, Elisa Gallerani, Gianluca Del Conte, Rafael Morales-Barrera, Philippe A. Cassier, Carlos Gomez-Roca, David Olmos, Victor Moreno García
Supplementary Figure 1. Study flowchart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7875c529173e96dd93bc25c70fbd6fa
https://doi.org/10.1158/1078-0432.22457858.v1
https://doi.org/10.1158/1078-0432.22457858.v1
Autor:
Stan B. Kaye, Jaap Verweij, Josep Tabernero, Jean Charles Soria, Richard H. Wilson, Ruth Plummer, Jeffrey Evans, Emile Voest, Nicolas Penel, Jan H.M. Schellens, Silvia Marsoni, Patrick Schöffski, Andre T. Brunetto, Elisa Gallerani, Gianluca Del Conte, Rafael Morales-Barrera, Philippe A. Cassier, Carlos Gomez-Roca, David Olmos, Victor Moreno García
Supplementary table 1. Main characteristics of patients receiving different dose levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a852e43df12b436b20c772bbd67fc9c
https://doi.org/10.1158/1078-0432.22457855.v1
https://doi.org/10.1158/1078-0432.22457855.v1
Autor:
Stan B. Kaye, Jaap Verweij, Josep Tabernero, Jean Charles Soria, Richard H. Wilson, Ruth Plummer, Jeffrey Evans, Emile Voest, Nicolas Penel, Jan H.M. Schellens, Silvia Marsoni, Patrick Schöffski, Andre T. Brunetto, Elisa Gallerani, Gianluca Del Conte, Rafael Morales-Barrera, Philippe A. Cassier, Carlos Gomez-Roca, David Olmos, Victor Moreno García
Supplementary table 3. Multivariate model for Overall Survival (Cytotoxic Agents)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3704753b656bbabbb08623df6d9bdfee
https://doi.org/10.1158/1078-0432.22457849.v1
https://doi.org/10.1158/1078-0432.22457849.v1
Autor:
Stan B. Kaye, Jaap Verweij, Josep Tabernero, Jean Charles Soria, Richard H. Wilson, Ruth Plummer, Jeffrey Evans, Emile Voest, Nicolas Penel, Jan H.M. Schellens, Silvia Marsoni, Patrick Schöffski, Andre T. Brunetto, Elisa Gallerani, Gianluca Del Conte, Rafael Morales-Barrera, Philippe A. Cassier, Carlos Gomez-Roca, David Olmos, Victor Moreno García
Introduction: Because a dose–response relationship is characteristic of conventional chemotherapy, this concept is widely used for the development of novel cytotoxic (CTX) drugs. However, the need to reach the MTD to obtain optimal benefit with mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8493d0c4d40757375b023a3cc460671b
https://doi.org/10.1158/1078-0432.c.6523727.v1
https://doi.org/10.1158/1078-0432.c.6523727.v1
Autor:
Stan B. Kaye, Jaap Verweij, Josep Tabernero, Jean Charles Soria, Richard H. Wilson, Ruth Plummer, Jeffrey Evans, Emile Voest, Nicolas Penel, Jan H.M. Schellens, Silvia Marsoni, Patrick Schöffski, Andre T. Brunetto, Elisa Gallerani, Gianluca Del Conte, Rafael Morales-Barrera, Philippe A. Cassier, Carlos Gomez-Roca, David Olmos, Victor Moreno García
Supplementary table 2. Multivariate model for overall survival (Molecularly Targeted Agents).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ac98c58d500bc6de6409f08f583f70b
https://doi.org/10.1158/1078-0432.22457852.v1
https://doi.org/10.1158/1078-0432.22457852.v1